menu Search
Search Drug Information, Images & Medical News

Search Drug Information, Images & Medical News | MIMS Hongkong

Advanced Search

 

MORE
Ethosuximide not supported for IBS pain management 20 Jan 2026
The T-type calcium channel blocker ethosuximide has shown limited benefit in the treatment of irritable bowel syndrome (IBS)-related abdominal pain in a proof-of-concept study.
Low-dose olanzapine as good as megestrol acetate for cancer anorexia–cachexia syndrome
20 Jan 2026
Does erythromycin/clindamycin resistance predict mortality in MSSA bacteremia?
20 Jan 2026
Use of sacituzumab govitecan safe, efficacious in pretreated mBC
20 Jan 2026
‘Difficult’ patients nag healthcare providers
20 Jan 2026
Genetic predisposition to higher BMI ups mortality risk in breast cancer survivors
19 Jan 2026
Metformin prevents ACS-induced maternal hyperglycaemia, neonatal hypoglycaemia
19 Jan 2026
5-year data back omission of sentinel lymph node biopsy in early-stage breast cancer
19 Jan 2026
Melatonin may reduce delirium burden in children admitted to ICU
19 Jan 2026
Sacituzumab govitecan proves real-world survival benefits in metastatic breast cancer
19 Jan 2026
PCSM model predicts long-term mortality risk from prostate cancer
19 Jan 2026
MORE
Rapid hair regrowth in a patient with alopecia universalis treated with a JAK3/TEC family kinase inhibitor 12 Jan 2026;
A 12-year-old boy presented with longstanding alopecia universalis (AU) in March 2024, with complete loss of scalp hair corresponding to a Severity of Alopecia Tool (SALT) score of 100, as well as loss of all eyebrows, eyelashes, and body hair. Responses to previous treatments were suboptimal. In September 2024, the patient (SALT 50) was switched to ritlecitinib 50 mg QD as it had become available in Hong Kong through a medication access programme. By February 2025, the patient’s SALT score had improved to 0–10 (complete scalp hair regrowth), with complete regrowth of eyebrows and eyelashes. 
Transforming ischaemic stroke care: Integrated networks, thrombolysis optimization and AI-assisted hyperacute care
Dr. David Hargroves, East Kent Hospitals University Foundation Trust, United Kingdom, 12 Jan 2026
From nontargeted therapy to CGRP-targeted therapy: Breakthrough in first-line migraine prevention
Dr. William Kingston, Division of Neurology, Department of Medicine, Temerty School of Medicine, University of Toronto, Canada, 29 Dec 2025
First patient treated with sotatercept for pulmonary arterial hypertension in HK’s public healthcare sector
Dr. Timothy Ka-Chun Un, Specialist in Cardiology, Queen Mary Hospital, 28 Dec 2025
SHOW ALL

New Molecule

2 New

New Formulation

1 New

New Indication

3 New

New Brand

5 New

A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
#
ADVANCED SEARCH
Markings
Shape
Form
Color 1
Color 2
Advertisement
MORE
Updates on the Classification, Diagnosis, and Treatment of Urinary Tract Infections (UTIs) in Adults
Doctors CME Unit: 0.5/1 point
Nourishing Motherhood: The Impact of Maternal Nutrition on Fertility, Pregnancy, and Early Childhood Health
Doctors CME Unit: 1 point
Primary Care Approach to the Management of Non-neurogenic Overactive Bladder
Doctors CME Unit: 1 point
Advertisement

MIMS is a trusted, accurate and user-friendly medication information platform. Designed to empower both healthcare professionals and general public to support informed healthcare decisions, our leading drug directory provides clear, reliable information on prescription drugs, over-the-counter medications and other medical resources.

Frequently Asked Questions

Absolutely. Our database is continuously updated by medical editors and references authoritative sources, ensuring accuracy and credibility.

Yes. You can access MIMS.com on desktop or mobile, and we also offer an app for on-the-go use.

Use the search bar located at the top of the homepage and enter either the brand name or generic name of the drug.

Go to "Diseases" and use the search bar located at the top of the page and enter the name of the disease.

Go to "Medical News & Updates" to access latest news and medical updates in MIMS.com
Explore More FAQs